Active substance
Insulin hm isophane mc
- SFDA 3
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| HUMULIN N100U/ML CARTRIDGE | 100 IU/ml | Solution for injection in cartridge · Subcutaneous use | 5 Cartridge | SAR 93.70 | Biological · Prescription | Eli Lilly and Company | Withdrawn by MAH · Not Marketed |
| INSULATARD HM 100 IU PENFILL | 100 IU/ml | Solution for injection in cartridge · Subcutaneous use | 5 Cartridge | SAR 62.65 | Biological · Prescription | NOVO NORDISK | Withdrawn by MAH · Not Marketed |
| INSULATARD PENFILL | 100 IU/ml | Suspension for injection · Subcutaneous use | 5 Cartridge | SAR 103.35 | Biological · Prescription | NOVO NORDISK | Invalid · Not Marketed |
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.